|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
03/22/2024 |
$15.24 |
$15.76 |
$15.03 |
$15.49 |
2.04M | 03/25/2024 |
$15.46 |
$15.82 |
$15.40 |
$15.69 |
1.77M | 03/26/2024 |
$15.83 |
$15.99 |
$15.24 |
$15.44 |
2.65M | 03/27/2024 |
$15.55 |
$15.62 |
$15.05 |
$15.57 |
1.45M | 03/28/2024 |
$15.56 |
$15.60 |
$15.14 |
$15.21 |
2.33M |
|
TG Therapeutics is a commercial stage biopharmaceutical company focused on the acquisition, development and commercialization of treatments for B-cell diseases. In addition to a research pipeline including several investigational medicines, Co. has received approval from the U.S. Food and Drug Administration for BRIUMVI (ublituximab-xiiy) for the treatment of adult patients with relapsing forms of multiple sclerosis, to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. Co. also evaluates products, technologies and companies for in-licensing, partnership, acquisition and/or investment opportunities. | |
|
TG Therapeutics (TGTX) has the following price history information. Looking back at TGTX historical stock prices for the last five trading days, on March 22, 2024, TGTX opened at $15.24, traded as high as $15.76 and as low as $15.03, and closed at $15.49. Trading volume was a total of 2.04M shares. On March 25, 2024, TGTX opened at $15.46, traded as high as $15.82 and as low as $15.40, and closed at $15.69. Trading volume was a total of 1.77M shares. On March 26, 2024, TGTX opened at $15.83, traded as high as $15.99 and as low as $15.24, and closed at $15.44. Trading volume was a total of 2.65M shares. On March 27, 2024, TGTX opened at $15.55, traded as high as $15.62 and as low as $15.05, and closed at $15.57. Trading volume was a total of 1.45M shares. On March 28, 2024, TGTX opened at $15.56, traded as high as $15.60 and as low as $15.14, and closed at $15.21. Trading volume was a total of 2.33M shares.
TGTX Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into TG Therapeutics shares, starting with a $10,000 purchase of TGTX, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/01/2014 |
|
End date: |
03/28/2024 |
|
Start price/share: |
$7.04 |
|
End price/share: |
$15.21 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
115.90% |
|
Average Annual Total Return: |
8.00% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$21,584.70 |
|
Years: |
10.00 |
|
|
|
Date |
Close |
03/22/2024 | $15.49 | 03/25/2024 | $15.69 | 03/26/2024 | $15.44 | 03/27/2024 | $15.57 | 03/28/2024 | $15.21 |
|
|